Dr. Martens plc (the "Company")

2024 Annual Report and Notice of Annual General Meeting

Further to the announcement of its preliminary results for the financial year ended 31 March 2024 and in accordance with Listing Rule 9.6.1, the Company announces that the following documents have been submitted in unedited full text to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism:

·      Annual Report and Accounts for the financial year ended 31 March 2024 (the "2024 Annual Report")

·      Notice of the 2024 Annual General Meeting (the "2024 Notice of Meeting"), which will take place at 9.30am on Thursday 11 July 2024 at Holiday Inn London - Camden Lock, 30 Jamestown Road, Camden, London, NW1 7BY

·      Proxy form for the 2024 Annual General Meeting

In compliance with rule 6.3.5R of the Disclosure Guidance and Transparency Rules, the 2024 Annual Report and 2024 Notice of Meeting are also available in unedited full text on the Company's website, www.drmartensplc.com.

For further information, please contact:
Paul Rolling, Assistant Company Secretary
+447584243562

Bethany Barnes, Director of Investor Relations
+447825187465

ENDS

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.